ALEXANDERS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ALEXANDERS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	227	231	233	226	199	206	206	225	226	213
General and administrative	5.44	5.26	5.34	5.77	6.31	5.92	6.11	6.34	6.52	6.56
Operating expenses	121	125	132	127	127	130	126	140	145	148
Operating income	105	105	101
Interest expense	22.2	31.5	44.5	38.9	24.2	19.7	28.6	58.3	62.8	51.6
Pre-tax income	86.5	80.5	56.6
Income tax	0.05	0	0
Income from continuing operations	86.5	80.5	56.6	60.1	41.9	131	57.6	102
Net income	86.5	80.5	32.8	60.1	41.9	133	57.6	102	43.4	28.2
EBITDA	142	144	139
EPS, basic	16.91	15.74	6.42	11.74	8.19	25.94	11.24	19.97	8.46	5.50
EPS, diluted	16.91	15.74	6.42	11.74	8.19	25.94	11.24	19.97	8.46	5.50
Shares, basic (weighted)	5.11	5.12	5.12	5.12	5.12	5.12	5.13	5.13	5.13	5.14
Shares, diluted (weighted)	5.11	5.12	5.12	5.12	5.12	5.12	5.13	5.13	5.13	5.14
Dividend per share		17.00	18.00	18.00	18.00	18.00	18.00	18.00	18.00	18.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	289	308	283	298	429	464	195	532	339	128
Short-term investments						0	267	0
Lease right-of-use assets				4.53	3.97	3.39	18.5	17.5	16.6	15.6
Total assets	1,451	1,632	1,286	1,266	1,404	1,392	1,398	1,404	1,341	1,111
Total liabilities	1,098	1,288	1,000	1,012	1,201	1,139	1,161	1,166	1,164	1,002
Paid-in capital	31.2	31.6	32	32.4	33	33.4	33.9	34.3	34.8	35.2
Retained earnings	309	303	248	216	166	207	172	182	133	69.2
Treasury stock	-0.37	-0.37	-0.37	-0.37	-0.37	-0.37	-0.37	-0.37	-0.37	-0.37
Other comprehensive income	7.86	5.03	-0.13	-0.05	-0.71	7.49	25.6	16.2	3.89	-0.01
Shareholders' equity	353	344	285	254	203	253	236	238	177	109
Total equity	353	344	285	254	203	253	236	238	177	109
Total liabilities and equity	1,451	1,632	1,286	1,266	1,404	1,392	1,398	1,404	1,341	1,111
Shares outstanding	5.11	5.11	5.11	5.11	5.11	5.11	5.11	5.11	5.11	5.11

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	86.5	80.5	32.8	60.1	41.9	133	57.6	102	43.4	28.2
Depreciation and amortization	36.4	38.7	38.5	36.5	35.1	34.6	31.5	34.5	37.9	38.1
Stock-based compensation		0.39	0.39	0.39	0.6	0.45	0.45	0.45	0.45	0.39
Change in receivables	0.96	0.36	-1.38	-2.02	-6.15	1.73	1.68	-0.57	0.17	1
Change in payables	16	0.21	-11.8	-1.8	2.36	12.5	3.14	3.26	-13.7	-1.42
Cash from operations	131	123	73.5	126	78.1	118	103	109	54.1	73.4
Purchases of investments					0	0	-364	0	0
Sales and maturities of investments				0	0	9.51
Cash from investing	-15.5	-202	-1.14	-9.45	-32.5	75.5	-279	322	-13.2	-20.8
Debt issued	0	500	78.2	0	240	0	0	0	400	175
Debt repaid	-3.44	-304	-160	0	-50	-68	0	0	-500	-335
Dividends paid	-81.8	-87	-92.1	-92.1	-92.2	-92.2	-92.3	-92.3	-92.4	-92.4
Cash from financing	-85.3	97.1	-176	-92.1	90.3	-160	-92.3	-92.4	-200	-254
Net change in cash	30	18.6	-104	24.5	136	33.6	-269	338	-159	-202
Interest paid	19.5	27	38.2	34.7	22.5	18.6	25.9	54	59.7	48.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $247.12 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Net margin	79.1%	Net income / revenue.
Operating cash flow margin	12.6%	Cash from operations / revenue.
Return on equity (ROE)	75.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	14.1%	Net income / average total assets.
D&A / revenue	16.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-35.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-21.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-7.6%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-35.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-21.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-7.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	35.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-10.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-1.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-38.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-22.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-11.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-17.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-7.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	81.4%	Total liabilities / total assets.
Tangible book value	$223.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.18x	Revenue / average total assets.

Per share

Metric	Value	How it is calculated
EPS, diluted	$33.05	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$41.81	Revenue / diluted weighted shares.
Operating cash flow per share	$5.29	Cash from operations / diluted weighted shares.
Book value per share	$43.79	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$43.79	Tangible book value / shares outstanding.
Cash per share	$59.39	(Cash + short-term investments) / shares outstanding.
Payout ratio	54.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.26B	Share price x shares outstanding.
Enterprise value	$958.8M	Market cap + total debt - cash - short-term investments.
P/E	7.43x	Market cap / net income. Only when net income is positive.
P/S	5.88x	Market cap / revenue.
P/B	5.64x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.64x	Market cap / tangible book value, when positive.
P/OCF	46.5x	Market cap / cash from operations, when positive.
EV/Sales	4.46x	Enterprise value / revenue.
Earnings yield	13.5%	Net income / market cap (the inverse of P/E).
Dividend yield	7.3%	Dividends paid over the period / market cap.
Shareholder yield	7.3%	(Dividends paid + share buybacks) / market cap.

What was ALEXANDERS INC's revenue in fiscal 2025?

ALEXANDERS INC reported revenue of $213.2M for fiscal 2025, 5.8% lower than the year before.

Was ALEXANDERS INC profitable in fiscal 2025?

Yes. Net income was $28.2M, a net margin of 13.2%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ALEXANDERS INC